UA90259C2 - CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASE - Google Patents
CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASEInfo
- Publication number
- UA90259C2 UA90259C2 UAA200609568A UAA200609568A UA90259C2 UA 90259 C2 UA90259 C2 UA 90259C2 UA A200609568 A UAA200609568 A UA A200609568A UA A200609568 A UAA200609568 A UA A200609568A UA 90259 C2 UA90259 C2 UA 90259C2
- Authority
- UA
- Ukraine
- Prior art keywords
- methyl
- diindolo
- ethylthio
- pyrrolo
- hexahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200400326 | 2004-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA90259C2 true UA90259C2 (en) | 2010-04-26 |
Family
ID=36607170
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200609568A UA90259C2 (en) | 2004-02-27 | 2005-02-24 | CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASE |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR20070012644A (ko) |
CN (1) | CN100591685C (ko) |
AR (1) | AR047821A1 (ko) |
CA (1) | CA2762878C (ko) |
EA (1) | EA200601566A1 (ko) |
ES (1) | ES2397342T3 (ko) |
HK (1) | HK1102087A1 (ko) |
TW (1) | TW200530254A (ko) |
UA (1) | UA90259C2 (ko) |
ZA (1) | ZA200606556B (ko) |
-
2005
- 2005-02-16 TW TW094104432A patent/TW200530254A/zh unknown
- 2005-02-24 ZA ZA200606556A patent/ZA200606556B/en unknown
- 2005-02-24 ES ES05706789T patent/ES2397342T3/es active Active
- 2005-02-24 EA EA200601566A patent/EA200601566A1/ru unknown
- 2005-02-24 AR ARP050100684A patent/AR047821A1/es not_active Application Discontinuation
- 2005-02-24 UA UAA200609568A patent/UA90259C2/ru unknown
- 2005-02-24 CN CN200580005979A patent/CN100591685C/zh not_active Expired - Fee Related
- 2005-02-24 KR KR1020067017263A patent/KR20070012644A/ko not_active Application Discontinuation
- 2005-02-24 CA CA2762878A patent/CA2762878C/en not_active Expired - Fee Related
-
2007
- 2007-06-27 HK HK07106856.3A patent/HK1102087A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN1922196A (zh) | 2007-02-28 |
TW200530254A (en) | 2005-09-16 |
CA2762878C (en) | 2014-08-19 |
HK1102087A1 (en) | 2007-11-02 |
ES2397342T3 (es) | 2013-03-06 |
ZA200606556B (en) | 2008-02-27 |
CA2762878A1 (en) | 2005-09-09 |
EA200601566A1 (ru) | 2006-12-29 |
CN100591685C (zh) | 2010-02-24 |
KR20070012644A (ko) | 2007-01-26 |
AR047821A1 (es) | 2006-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1122808A1 (en) | Preparation and use of tetrahydropyrrolo [3, 2-c]t pyridin-4-one derivatives for treatment of obesitty, psychiatric and neurological disorders | |
WO2007120752A3 (en) | 4, 5-dihydro- [1, 2, 4] triazolo [4, 3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders | |
WO2006107771A3 (en) | PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS | |
WO2006107853A3 (en) | Pyrazolopyridine-1,4-diamines and analogs thereof | |
WO2006122806A3 (en) | 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors | |
WO2005009370A3 (en) | Beta-carboline compounds and analogues thereof and their use as mitogen-activated protein kinase-activated protein kinase-2 inhibitors | |
EA200800992A1 (ru) | 2-амино-7,8-дигидро-6н-пиридо[4,3-d]пиримидин-5-оны, способ их получения, способ терапии с их помощью, компонент композиции и композиция на их основе, 2,4-диоксопиперидиновые соединения для их получения | |
GB0330043D0 (en) | Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them | |
AU2003267203A1 (en) | Method for administering thermotherapy to prevent the growth of tumors | |
WO2009151997A8 (en) | Process for producing bicycloaniline derivatives | |
TW200716589A (en) | Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole | |
IL191160A (en) | Use of pyrido [3,2- b] pyrazine-6-yl urine urine for the preparation of drugs to treat diseases caused by the enzyme pi3k inhibition. | |
IL189276A0 (en) | Novel crystalline form of a pyridazino [4,5-b] indole derivative | |
IL196517A (en) | Use of (12r, 10s, 9s) –– 10– Hydroxy – 10 – Hydroxymethyl –– 9 – Methyl – 12,11,10,9,3,2 – Hexahydro-12,9-Epoxy-H1-Diindolo [1 , 2,3 – fg: 3 ′, 2 ′, 1′ – kl] pyrrolo [3,4– i] –6,1– benzodiazomine-1-one for the preparation of a drug for the treatment of myelo-proliferative diseases associated with jak2 activation | |
PT1730144E (pt) | Compostos de 1,4,8-triaza-espiro[4.5]decan-2-ona substituídos | |
SI1685125T1 (sl) | Derivati pirola, primerni za zdravljenje proliferativnih bolezni | |
WO2006027370A8 (en) | PREPARATION OF 9-HYDROXY-3- (2-HYDROXYETHYL) -2-METHYL-4H-PYRID0[1, 2-a] PYRIMIDIN-4-ONE AND CRYSTALS THEREOF | |
WO2008100448A3 (en) | Method of treating cell proliferative disorders using growth hormone secretagogues | |
ZA200809016B (en) | 4, 5-Dihydro-[1,2,4] Triazolo [4,3-F] PteridinesS as protein kinase PLK1 inhibitors for the treatment of proliferative disorders | |
UA90259C2 (en) | CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASE | |
IL187441A0 (en) | Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid | |
AU2003256006A1 (en) | Improved process for preparation of risperidone | |
IL176471A0 (en) | Process for the preparation of triazolopyrimidines | |
ZA200605930B (en) | Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxyl}ethyl}-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one | |
NO20064348L (no) | Krystallinske former av en farmasoytisk forbindelse |